Artificial Intelligence in Healthcare- An Overview
Lakshmidevi Sigatapu, S. Sundar, K. Padmalatha, Sravya. K, D. Ooha, P. Uha Devi
Department of Pharmacology, Vijaya Institute of Pharmaceutical Sciences for Women, Enikepadu,
Vijayawada, Krishna (Dt), Andhra Pradesh, India.
*Corresponding Author E-mail: vipwlakshmidevi77@gmail.com
ABSTRACT:
Artificial intelligence (AI) has been developing fleetly in recent times in terms of software algorithms, tackle preparation, and operations in a vast number of areas. In this review, we epitomize the rearmost of operations of AI in biomedicine, including complaint diagnostics, living backing, biomedical information processing, and biomedical exploration. The end of this review is to keep track of new scientific accomplishments, to understand the vacuity of technologies, to appreciate the tremendous eventuality of AI in biomedicine, and to give experimenters in affiliated field’s alleviation. It can be asserted that, just like AI itself, the operation of AI in biomedicine is still in its early stage. New progress and improvements will continue to push the frontier and widen the compass of AI operations, and fast developments are envisaged in the near future.AI in healthcare is an umbrella term to describe the application of machine learning (ML) algorithms and other cognitive technologies in medical settings. In the simplest sense, AI is when computers and other machines mimic human cognition, and are capable of learning, thinking, and making decisions or taking actions. Artificial intelligence (AI) is gradationally changing medical practice. With recent progress in digitized data accession, machine literacy and computing structure, AI operations are expanding into areas that were preliminary allowed to be only the fiefdom of mortal experts. In this Review composition, we outline recent breakthroughs in AI technologies and their biomedical applications, identify the challenges for further progress in medical AI systems, and epitomize the profitable, legal and counteraccusations of AI in healthcare.
KEYWORDS: Artificial intelligence, Biomedical Research, Biomedicine, Operations, Cancer.
INTRODUCTION:
The term "artificial intelligence" had preliminary been used to describe machines that mimic and display "mortal" cognitive chops that are associated with the mortal mind, similar to "learning" and "problem-working". Artificial intelligence in healthcare is an overarching term used to describe the use of machine-learning algorithms and software, or artificial intelligence (AI), to mimic mortal cognition in the analysis, donation, and appreciation of complex medical data. Specifically, AI is the capability of computer algorithms to compare conclusions grounded solely on input data. The primary end of health-related AI operations is to dissect connections between clinical ways and patient issues1.
Fig No: 1 Artificial Intelligence in Healthcare
AI programs are applied to practices similar to diagnostics, treatment protocol development, medicine development, substantiated drug, and patient monitoring and care.
INDUSTRIES USE THE ARTIFICIAL INTELLIGENCE:
A- Automotive B- Biosciences C- Creative services D- Data E- Education F- Finance G- Gaming H- Healthcare I- Internet of things.
Finance:
Artificial intelligence is brought for digitalisation of banks then competing with fin-tech players becomes easy. The main reason for me to do artificial intelligence as a topic was due to the fact that A.I and machines are the future. The main focus I kept on A.I2.
TYPES OF AI IN HEALTHCARE:
Machine learning:
Machine learning is a statistical fashion for befitting models to data and to ‘learn’ by training models with data. In healthcare, the most common operation of traditional machine literacy is perfection drug – prognosticating what treatment protocols are likely to succeed in a case grounded on different patient attributes and the treatment. A more complex form of machine literacy is the neural network – a technology that has been available since the 1960s has been well-established in healthcare exploration for several decades and has been used for categorization operations like determining whether a case will acquire a particular complaint. A common operation of deep literacy in healthcare is recognition of potentially cancerous lesions in radiology images. Machine learning as a branch of Artificial Intelligence is growing at a very rapid pace. It has shown significant benefits across a number of different industry verticals in helping them improve their productivity and making them less reliant on humans. The success and the growth of any industry depends on the manageability of massive data, using the data for predictions and deriving business value, automating the processes without the need of human intervention, provide satisfactory services to their clients and the security of client's information.
Natural language processing:
This field, NLP, includes operations similar to speech recognition, textbook analysis, translation, and other goals related to language. There are two introductory approaches to it: statistical and semantic NLP. In healthcare, the dominant operations of NLP involve the creation, understanding, and bracket of clinical attestation and published exploration. NLP systems can dissect unshaped clinical notes on cases, prepare reports (e.g., radiology examinations), transcribe patient results, and conduct conversational AI.
Rule-based expert systems:
In healthcare, they were considerably employed for ‘clinical decision support’ purposes over the last couple of decades and are still in wide use moment. Multitudinous electronic health records (EHR) providers furnish a set of rules with their systems moment. They’re slugging being replaced in healthcare by farther approaches predicated on data and machine knowledge algorithms. Expert systems bear mortal experts and knowledge masterminds to construct a series of rules in a particular knowledge sphere. They work well up to a point and are easy to understand. However, when the number of rules is large (generally over several thousand) and the rules begin to discord with each other, they tend to break down2.
Physical robots:
Physical robots are well known by this point, given that further than 200,000 artificial robots are installed each time around the world. They perform pre-defined tasks like lifting, displacing, welding, or assembling objects in places like manufactories and storages and delivering inventories in hospitals. Surgical robots originally approved in the USA in 2000, give ‘superpowers’ to surgeons, perfecting their capability to see, produce precise and minimally invasive lacerations, sew injuries, and so forth3.
Fig No: 2 Physical Robots used in Artificial Intelligence
Robotic process automation:
This technology performs structured digital tasks for executive purposes, i.e., those involving information systems as if they were a mortal stoner following a script or rules. In healthcare, they are used for repetitious tasks like previous authorization, streamlining case records, or billing. Compared to other forms of AI they are affordable, easy to program and transparent in their conduct. Robotization doesn't really involve robots – only computer programs on waiters. It relies on a combination of workflow, business rules and ‘donation sub caste’ integration with information systems to act like a semi-intelligent stoner of the systems.
HOW AI WORKS IN HEALTHCARE:
· Teams of clinicians, researchers or data managers involved in clinical trials can speed up the process of medical coding search and confirmation, crucial in conducting and concluding clinical studies.
· Healthcare payers can personalize their health plans by connecting a virtual agent via conversational AI with members interested in customized health solutions.
· Clinicians can improve and customize care to patients by combing through medical data to predict or diagnose disease faster.
CLINICAL APPLICATIONS:
Cardiovascular:
Artificial intelligence algorithms have shown promising results in accurately diagnosing and risk-stratifying patients with concern for coronary artery disease; other algorithms have been used in predicting patient mortality, medication effects, and adverse events following treatment for acute coronary syndrome4. Another growing area of research is the utility of AI in classifying heart sounds and diagnosing valvular disease. Wearable’s, smart phones, and internet-grounded technologies have also shown the capability to cover cases cardiac data points, expanding the quantum of data and the colorful settings AI models can use and potentially enabling earlier detection of cardiac events occurring outside of the hospital. Another growing area of exploration is mileage of AI in classifying heart sounds and diagnosing valvular complaint. Challenges of AI in cardiovascular drug have included the limited data available to train machine literacy models, similar limited data on social determinants of health as they pertain to cardiovascular complaint5.
Dermatology:
Dermatology is an imaging-abundant specialty and the development of deep literacy has been explosively tied to image processing. There are 3 main imaging types in dermatology: contextual images, macro images, and micro images. For each modality, deep literacy showed great progress and showed keratinolytic skin cancer confirming from face photos demonstrating dermatologist-position bracket of skin cancer from lesion images thus, there is a natural fit between the dermatology and deep literacy. For each modality, deep literacy showed great progress. Han showed keratinolytic skin cancer detection from face photographs.
One of the scientists demonstrated dermatologist-level classification of skin cancer from lesion images6. Recent advances have suggested the use of AI to describe and estimate the outgrowth of maxillo-facial surgery or the assessment of cleft palate remedy in regard to facial attractiveness or age appearance. In 2018, a paper published in the journal Annals of Oncology mentioned that skin cancer could be detected more directly by an artificial intelligence system (which used a deep literacy convolutional neural network) than by dermatologists. On average, the mortal dermatologists directly detected 86.6% of skin cancers from the images, compared to 95% for the CNN machine7.
Gastroenterology:
AI can play a part in different angles of the field of gastroenterology. Endoscopic examinations similar to esophagus gastro duodenoscopies (EGD) and colonoscopies calculate the rapid-fire discovery of an abnormal group of cells. By enhancing these endoscopic procedures with AI, clinicians can more fleetly identify conditions; determine their inflexibility, and fantasize about eyeless spots. Inflammation of the GIT reduces its capability to work accurately in IBD. Both Crohn’s disease and ulcerative colitis are the most common form of inflammatory bowel disease and affected the inflammation and remission of patients. These diseases are mostly affecting the quality of life of people.
Fig No: 3 Image Analyses by Artificial Intelligence
Oncology:
AI has been explored for use in cancer tests, threat positions, molecular characterization of excrescences, and cancer medicine discovery. A particular challenge in oncologic care that AI is being developed to address is the capability to directly prognosticate which treatment protocols will be best suited for each case grounded on their individual inheritable, molecular, and excrescence-grounded characteristics. Through its capability to translate images to fine sequences, AI has been trialed in cancer diagnostics with the reading of imaging studies and pathology slides. In January 2020, experimenters demonstrated an AI system, grounded on a Google Deep Mind algorithm, able of surpassing mortal experts in breast cancer detection. it was reported that an AI algorithm developed by the University of Pittsburgh achieves the loftiest delicacy to date in relating prostate cancer, with 98% perceptivity and 97% particularity. Many biological functions have been described for naringin as anticancer, as well as inhibiting cell proliferation in several human cancer cell lines, including those of the stomach, colon, pancreas, breast, liver, and lung. In addition, naringin can prevent the formation of new blood vessels, induced apoptosis in cancer cells, surpress the release of a tumor necrosis factor and prevent hepatocellular damage induced by toxins, such us lipopolysaccharide, inhibiting protein kinase. Naringin has been known as suppressing and blocking agents to control cancer cells. The RMS values allow us to understand the ability of the molecule to reproduce the correct conformation that is the most ideal for binding and hence most suitable. Since, the RMS of the other receptors was very high indicating that meaningful interaction between the receptor and ligand is unlikely8.
Fig No: 4 Cancer diagnoses through Artificial Intelligence
Pathology:
AI-supported pathology tools help developed to assist with the tests of a number of conditions, including hepatitis B, gastric cancer, and colorectal cancer.AI has also been used to prognosticate inheritable mutations and prognosticate complaint outcomes8. AI is well-suited for use in low-complexity pathological analysis of large-scale webbing samples, similar colorectal cancer screening, therefore lessening the burden on pathologists and allowing for faster reversal of sample analysis.
Several deep literacy and artificial neural network models have shown delicacy analogous to that mortal pathologist, and a study of deep literacy backing in diagnosing metastatic breast cancer in lymph bumps showed that the delicacy of humans with the assistance of a deep literacy program was advanced than either the humans alone or preparation. Additionally, implementation of digital pathology is prognosticated to save over $12 million for a university center over the course of five years, though savings attributed to AI extensively have not yet been widely researched.
Telemedicine:
The increase of telemedicine, the treatment of cases ever, has shown the rise of possible AI operations. AI can help in minding cases ever by covering their information through detectors9. A wearable device may allow for constant monitoring of a case and the capability to notice changes that may be less distinguishable by humans. The information can be compared to other data that has formerly been collected using artificial intelligence algorithms that warn doctors if there are any issues to be apprehensive of. Another operation of artificial intelligence is chat-bot therapy. Some experimenters charge that the reliance on chat bots for internal healthcare does not offer the reciprocity and responsibility of care that should live in the relationship between the consumer of internal healthcare and the care provider (be it a chat-bot or psychologist), however. Since the average age has risen due to a longer life expectation, artificial intelligence could be useful in helping take care of aged population tools similar terrain and particular sensors can identify a person's regular conditioning and alert a caretaker if a geste or a measured vital is abnormal. Although the technology is useful, there are also conversations about limitations of monitoring in order to admire a person's sequestration since there are technologies that are designed to collude out home layouts and descry mortal relations.
Fig No: 5 Telemedicine using Artificial Intelligence
ETHICAL IMPLICATIONS:
Eventually, there are also a variety of ethical counteraccusations around the use of AI in healthcare. Healthcare opinions have been made nearly simply by humans in history, and the use of smart machines to make or help with them raises issues of responsibility, translucency, authorization, and sequestration. May be the most delicate issue to address given the moment's technologies is translucency. There are also likely to be incidents in which cases admit medical information from AI systems that they would prefer to admit from a compassionate clinician.
THE FUTURE OF AI IN HEALTHCARE:
The future of AI in healthcare we believe that AI has an important part to play in the healthcare immolations of the future. In the form of machine literacy, it is the primary capability behind the development of the perfect drug, extensively agreed to be a plaintively demanded advance in care. Although early sweating at furnishing opinions and treatment recommendations has proven grueling, we anticipate that AI will eventually master that sphere as well. Given the rapid fire in AI for imaging analysis, it seems likely that the utmost radiology and pathology images will be examined at some point by a machine. Speech and textbooks are formerly employed for tasks like patient communication and prisoner of clinical notes, and their operation will increase.
CONCLUSION:
The precision drug is progressing but with numerous challenges lying ahead which beartheaddition of useful logical tools, technologies, databases, and approaches to efficiently compounding networking and interoperability of clinical, laboratory, and public health systems, as well as address ethical and social issues related to sequestration and protection of healthcare and omics data with effective balance.
ACKNOWLEDGEMENT:
The authors acknowledge to Vijaya Institute of Pharmaceutical Sciences for Women, Vijayawada for their valuable support to complete the review work in a successful manner.
CONFLICT OF INTEREST:
The authors declare no conflict of interest.
REFERENCES:
1. Coiera E (1997). Guide to medical informatics, the Internet and telemedicine. Chapman & Hall, Ltd. Taylor and Francis Group3rd Edition18 March 2015, 620.
2. Rashmi R., Nirmal Raj VK. A Study on the Implementation and the Impact of Artificial Intelligence in Banking Processes. Asian Journal of Management. 2021; 12(1):47-54
3. Fakoor R, Ladhak F, Nazi A, Huber M. Using deep learning to enhance cancer diagnosis and classification. A conference presentation. The 30th International Conference on Machine Learning, 2013.
4. Davenport TH, Glaser J. Just-in-time delivery comes to knowledge management. Harv Bus Rev. 2002 Jul; 80(7):107-11, 126.
5. Wang H, Zu Q, Chen J, Yang Z, Ahmed MA. Application of Artificial Intelligence in Acute Coronary Syndrome: A Brief Literature Review. Adv Ther. 2021 Oct; 38(10):5078-5086. https://doi.org/10.1007/s12325-021-01908-2
6. Stewart J, Lu J, Goudie A, Bennamoun M, Sprivulis P, Sanfillipo F, Dwivedi G. Applications of machine learning to undifferentiated chest pain in the emergency department: A systematic review. PLoS One. 2021 Aug 24; 16(8):e0252612. doi: 10.1371/journal.pone.0252612
7. Amaq Fadholly, Arif N. M. Ansori, Teguh H. Sucipto. An Overview of Naringin: Potential Anticancer compound of Citrus Fruits. Research J. Pharm. and Tech. 2020; 13(11):5613-5619.
8. Han SS, Moon IJ, Lim W, Suh IS, Lee SY, Na JI, Kim SH, Chang SE. Keratinocytic Skin Cancer Detection on the Face Using Region-Based Convolutional Neural Network. JAMA Dermatol. 2020 Jan 1; 156(1):29-37. doi: 10.1001/jamadermatol.2019.3807.
9. Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S. Corrigendum: Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017 Jun 28; 546(7660):686. doi: 10.1038/nature22985.
10. Försch S, Klauschen F, Hufnagl P, Roth W. Artificial Intelligence in Pathology. DtschArztebl Int. 2021 Mar 26; 118(12):194-204.
11. Pivovarov R, Elhadad N. Automated methods for the summarization of electronic health records. J Am Med Inform Assoc. 2015 Sep; 22(5):938-47. doi: 10.1093/jamia/ocv032.
12. Han SS, Moon IJ, Lim W, Suh IS, Lee SY, Na JI, Kim SH, Chang SE. Keratinocytic Skin Cancer Detection on the Face Using Region-Based Convolutional Neural Network. JAMA Dermatol. 2020 Jan 1; 156(1):29-37.
13. Halima Afroz Lari, Kuhu Vaishnava, Manu K S. Artifical Intelligence in E-commerce: Applications, Implications and Challenges. Asian Journal of Management. 2022; 13(3):235-4.
14. Sahil Mahajan, Heemani Dave, Santosh Bothe, Debarshikar Mahpatra, Sandeep Sonawane, Sanjay Kshirsagar, Santosh Chhajed. Objective Monitoring of Cardiovascular Biomarkers using Artificial Intelligence (AI). Asian Journal of Pharmaceutical Research. 2022; 12(3):229-4.
15. Ajay I. Patel, Pooja K. Khunti, Amit J. Vyas, Ashok B. Patel. Explicating Artificial Intelligence: Applications in Medicine and Pharmacy. Asian Journal of Pharmacy and Technology; 12(4):401-6.
16. Anitha A, Revathi SV, Jeevanantham S, Eliza Godwin E. Intrusion Detection System based on Artificial Intelligence. Int. J. Tech. 2017; 7(1): 20-2.
17. Patel Minesh. A Review on Importance of Artificial Intelligence in Alzheimer’s Disease and it’s Future Outcomes for Alzheimer’s Disease. Research Journal of Pharmacology and Pharmacodynamics.2022; 14(1):13-2.
18. Rohitas Deshmukh, Sujata Kumari, Ranjit K. Harwansh. Inflammatory Bowel Disease: A Snapshot of Current Knowledge. Research J. Pharm. and Tech 2020; 13(2):956-962.
19. S Narendra Kumar, Chetan D M, Lingayya Hiremath, Ajeet Kumar Srivastava, Muralidhara P L, Jyothsana R, Rithika Pravin Iye, Ruchika Pravin Iyer. Molecular Docking studies of THC-HCA on Cancer Receptors. Research Journal of Pharmacy and Technology. 2022; 15(7):3195-9.
20. Neha Bhateja, Nishu Sethi, Shivangi Kaushal. Machine Learning and its role in Diverse Business Systems. Research Journal of Science and Technology. 2021; 13(3):213-7.
Received on 20.01.2023 Modified on 01.04.2023
Accepted on 10.06.2023 ©Asian Pharma Press All Right Reserved
Asian J. Pharm. Tech. 2023; 13(3):218-222.
DOI: 10.52711/2231-5713.2023.00039